AGC Biologics, a global therapeutic protein production company, announced yesterday that it has named Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.
Holt will offer leadership and site management overseeing delivery of contract development and manufacturing services.
Holt has more than 20 years of leadership experience in the biotechnology and manufacturing industry, having worked for Lonza, DSM/Patheon and GlaxoSmithKline in the US and Europe.
Moderna and Catalent Team for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine Candidate
Akeso names new lead gynecologic oncology advisor and chair of the Steering Committee
Therapeutics Solutions International plans to use StemVacs for COVID-19 patient treatment
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
Epsilen Bio Names Berretta as Chief Executive Officer and Simon as Chairman of the Board
CANbridge Pharmaceuticals appoints Carrie Ann Cook new SVP/global head of Business Development